Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Gill

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
Nature Medicine|September 27, 2024
Cytokine-mediated CAR T therapy resistance in AMLAnand S Bhagwat, Leonel Torres, Olga Shestova, et al.
Nature Genetics|November 13, 2012
The genetic landscape of mutations in Burkitt lymphomaCassandra Love, Zhen Sun, Dereje Jima, et al.
Nature|December 8, 2022
Author Correction: Decade-long leukaemia remissions with persistence of CD4<sup>+</sup> CAR T cellsJ Joseph Melenhorst, Gregory M Chen, Meng Wang, et al.
Blood Advances|August 19, 2025
International Consensus Guidelines for the Conduct and Reporting of CAR T-Cell Clinical Trials in AMLSwati Naik, Richard Aplenc, Susanne H C Baumeister, et al.
Nature|February 3, 2022
Decade-long leukaemia remissions with persistence of CD4<sup>+</sup> CAR T cellsJ Joseph Melenhorst, Gregory M Chen, Meng Wang, et al.
Blood|August 25, 2010
Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAsDereje D Jima, Jenny Zhang, Cassandra Jacobs, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2013
Genetic heterogeneity of diffuse large B-cell lymphomaJenny Zhang, Vladimir Grubor, Cassandra L Love, et al.
Nature Biomedical Engineering|March 10, 2026
Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancerGregory M Chen, Ankita Jain, David T Gering, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 22, 2018
Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow TransplantationAnkit J Kansagra, Noelle V Frey, Merav Bar, et al.
Bone Marrow Transplantation|May 17, 2019
Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT)Ankit J Kansagra, Noelle V Frey, Merav Bar, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Nature Medicine|September 27, 2024
Cytokine-mediated CAR T therapy resistance in AMLAnand S Bhagwat, Leonel Torres, Olga Shestova, et al.
Nature Genetics|November 13, 2012
The genetic landscape of mutations in Burkitt lymphomaCassandra Love, Zhen Sun, Dereje Jima, et al.
Nature|December 8, 2022
Author Correction: Decade-long leukaemia remissions with persistence of CD4<sup>+</sup> CAR T cellsJ Joseph Melenhorst, Gregory M Chen, Meng Wang, et al.
Blood Advances|August 19, 2025
International Consensus Guidelines for the Conduct and Reporting of CAR T-Cell Clinical Trials in AMLSwati Naik, Richard Aplenc, Susanne H C Baumeister, et al.
Nature|February 3, 2022
Decade-long leukaemia remissions with persistence of CD4<sup>+</sup> CAR T cellsJ Joseph Melenhorst, Gregory M Chen, Meng Wang, et al.
Blood|August 25, 2010
Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAsDereje D Jima, Jenny Zhang, Cassandra Jacobs, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 8, 2013
Genetic heterogeneity of diffuse large B-cell lymphomaJenny Zhang, Vladimir Grubor, Cassandra L Love, et al.
Nature Biomedical Engineering|March 10, 2026
Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancerGregory M Chen, Ankita Jain, David T Gering, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 22, 2018
Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow TransplantationAnkit J Kansagra, Noelle V Frey, Merav Bar, et al.
Bone Marrow Transplantation|May 17, 2019
Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT)Ankit J Kansagra, Noelle V Frey, Merav Bar, et al.
Pageof 15